Cita APA

Dhainaut, J., Antonelli, M., Wright, P., Belger, M., Cobas-Meyer, M., Mignini, M., & Janes, J. (2008). Extended drotrecogin alfa (activated) therapy in patients with persistent requirement for vasopressor support after 96-hour infusion with commercial drotrecogin alfa (activated). BioMed Central.

Chicago Style Citation

Dhainaut, J., M. Antonelli, P. Wright, M. Belger, M. Cobas-Meyer, M. Mignini, i J. Janes. Extended Drotrecogin Alfa (activated) Therapy in Patients With Persistent Requirement for Vasopressor Support After 96-hour Infusion With Commercial Drotrecogin Alfa (activated). BioMed Central, 2008.

Cita MLA

Dhainaut, J., et al. Extended Drotrecogin Alfa (activated) Therapy in Patients With Persistent Requirement for Vasopressor Support After 96-hour Infusion With Commercial Drotrecogin Alfa (activated). BioMed Central, 2008.